What a load of BS. The Brilacidin-ABSSSI clinical trial is expensive because it requires a very large number of participants. The management stated clearly that it was being deferred precisely because the other clinical trials were far cheaper and could be concluded quickly. To claim that the other clinical trials "will not be significantly different than any other Phase 3" is completely untrue. Your premise is that all Phase 3 clinical trials cost the same? Laughable, and wrong.

Please do not think that you can baffle us with your BS here. You will continue to be called out on your misstatements.

There's really nothing to be gained for you to be posting here because, unlike lieHUB, the people here are knowledgeable and not fooled by well-written distortions of the truth. Save your efforts for other boards, because you're not getting any traction here.